Tonix Pharmaceuticals Holding Corp. (TNXP)
Develops drugs for migraines, depression, rare diseases, and infectious conditions.
$10.19-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-73.9%
The outlook
Tonix Pharmaceuticals trades at $10.19, near its 52-week low with price sitting well below both its 50- and 200-day moving averages, suggesting a downtrend. Analyst consensus is bullish, with an average price target implying significant upside from current levels, though coverage remains limited at five analysts. The overall sentiment is neutral, reflecting tension between the bearish price action and constructive analyst views.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +314% vs current price
Analyst price target
~12-month · 5 analysts$42.20average target+314.1% vs now
Now $10.19
Low $22.00High $65.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$162.4M
52-wk high
$69.97
52-wk low
$9.81
50-day avg
$12.18
200-day avg
$15.05
Trailing P/E
—